Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer. - Wikidata - awgldk - TriplyDB

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

http://www.wikidata.org/entity/Q36800215

about

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis Relevance of tumor-infiltrating lymphocytes in breast cancer Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation Harnessing the power of Vδ2 cells in cancer immunotherapy Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes.Plasticity of γδ T Cells: Impact on the Anti-Tumor Response Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas.IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.Specific recruitment of γδ regulatory T cells in human breast cancer.Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia Primary cutaneous B-cell lymphoma with abundant reactive gamma/delta T-cells within the skin lesion and peripheral blood.Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects.Human γδT-cell subsets and their involvement in tumor immunity.The tumor microenvironment: a pitch for multiple players.Deciphering and reversing tumor immune suppression.Adoptive immunotherapy of metastatic breast cancer: present and future.Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?Overcoming tumor-mediated immunosuppression.Human gamma delta T regulatory cells in cancer: fact or fiction?Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.γδ T cells in cancer.IL-2 Shapes the Survival and Plasticity of IL-17-Producing γδ T Cells.γδ T cell-based anticancer immunotherapy: progress and possibilities.Characterization of γδ T cells in patients with non-small cell lung cancer.Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.Systemic inflammation: Cancer's long-distance reach to maximize metastasis.Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model.Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes.

P2860

Q26748691-5BA6C594-F2CC-4695-81FC-15DCC38C6DD2 Q26795598-F14AA8F9-2540-40F3-AD31-4A99B1CC8748 Q26863724-33D3133D-487A-40FA-ACAF-C5C6433ECC1E Q27027547-3D174815-271A-4661-92D0-CC6EC9231563 Q33855566-1FE13F63-1E0E-4ACB-A26C-4E3ED74346AA Q34119854-A6EE6AA0-470B-4DA0-896D-DFDBC4AF7DD4 Q34393311-DB823969-5D57-4179-B91E-3CEA1F1848D3 Q34652408-1E9F0609-B752-4AD9-B1B1-130CAF957A79 Q34668723-8476AC05-5310-4AD0-80A1-8886A7E7AC5E Q35763387-7D11A563-9581-49AC-BF17-B058ACE715C1 Q36085104-8D61C023-6533-49A3-AFCA-73C121AC985C Q36232078-63B56BA0-A73F-4CA7-B6FF-4729D7F061E4 Q36471557-01C79158-E207-41C6-9A7F-50192FC2D391 Q36625669-53CE4184-791C-40E4-86F3-EA01E74D885B Q36759195-6DE8C49B-8927-4B90-87A5-65A5D4172D39 Q36772903-3266F6CA-3DED-473A-BA38-4E2E5EC585CF Q37238831-D83E6A63-E5F0-4278-BBB1-21E4A7568025 Q37423895-BB499B2E-E1D6-41A0-83AC-9367E2E613E6 Q37676801-73AEDA7E-60DC-4AAA-85D4-40FE9FA98D5A Q37706085-7E883D15-29A5-4945-9635-5F5AC2EB69AB Q37714642-25C84DC5-AB05-49B4-BF6F-742CE5FFBB7E Q38101567-DC7F41F5-F504-4163-AA38-C4BA446DF570 Q38124437-5D614514-535C-40E8-8D9D-F90C8D89F92C Q38171325-0C0AE836-744A-4DBE-93AE-C273137CCF8C Q38217512-582753D7-3253-45D7-81DE-493C265558F9 Q38262255-480A1A28-8F2A-4571-A922-A22D03943D2B Q38283534-0928CF2E-BD49-45F9-B748-B43E6DFCD361 Q38283536-EB514A69-2FD0-4EBF-8A05-E4745F00B909 Q38287973-9BECC53D-2BCD-4B20-BF04-2C7886A2CA43 Q38602555-3B10D309-41C8-4B4D-93C7-8885299FEC03 Q38611201-42F28AD5-1DFA-4DDB-AEF6-F4D498D3AD03 Q38633738-D3EB907C-2B08-4637-893C-486A0B38D064 Q38685999-62924F5C-9769-4D55-B37C-7A59FF7E645E Q38787725-AF2B0CE9-BD29-456B-A187-35845FB59287 Q38839115-990A2E00-BBBF-4D25-A5F6-7FA9C7E11570 Q38848219-809F40B8-83F9-4BEF-BFC8-9E1B227B6918 Q39160154-12796D25-03F5-4F8A-9F18-2295FF439844 Q39279591-E8E2A701-BD55-4BE6-95C0-0DBC3E44775A Q40146526-858EA934-909A-4AAF-BE40-54FD59F78D6C Q40724889-86E1D1B4-FD19-4E1D-9484-DD9610AA6770

P2860

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

http://www.wikidata.org/entity/Q36800215

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

@ast

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

@en

type

label

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

@ast

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

@en

prefLabel

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

@ast

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

@en

P1433

Q36800215-7607522D-2394-42ED-8186-9D59306D3319

P1476

Q36800215-2A7575FE-5197-4835-B204-A792744F8500

P2093

Q36800215-0490CE86-BD0A-4C3D-8FBF-1D51A1C77F0F

Q36800215-14DC879D-F38A-4EC4-A12F-9E5A0686E499

Q36800215-1E5AFEB1-8298-47DB-A338-59EA66B25201

Q36800215-1F185BF8-D564-4C2D-8FC8-2B8B16D0B053

Q36800215-336042A2-5323-4D96-A73F-DD43CF4C9951

Q36800215-576C2B32-9AFF-4969-8E34-D83DD90AC309

Q36800215-5BC7CED4-E744-4A7A-888E-8AD7B5FF2143

Q36800215-7B083613-F8E8-4A78-AF8D-93C00EA8CA81

Q36800215-885648D3-C715-455E-B430-D116BA62C96C

Q36800215-B4913B3D-AC93-4894-86E3-526A04B0C41F

P2860

Q36800215-1B2C5D7C-59F7-4692-91A6-E1B02F0A641D

Q36800215-1B3FD4A9-0438-423D-A5D7-4F9F7ED79DD2

Q36800215-1D71D14A-E28E-4895-97E9-3BDE6417285D

Q36800215-1E336E94-2CCF-45E9-9A0F-3DFB9A0A5A62

Q36800215-1E4ED41E-BF65-44C9-8FF8-6F9C6315B50A

Q36800215-2DC69F60-2387-4766-8230-0165A7B87478

Q36800215-2F6DAFC0-CC7D-49E7-8494-49FB3C8BE3B1

Q36800215-362B7E65-5AAB-4E16-8ADC-F12C89687442

Q36800215-3B19B43D-D02F-46B7-8B7A-D38A7287821A

Q36800215-471AA500-D8B2-47B4-B986-43FC8158953D

P304

Q36800215-D07E0FD0-5CD5-4FA5-92C2-80ED243D8832

P31

Q36800215-686A1034-5D1A-4AC4-82D4-DDA6DA38E09C

P356

Q36800215-2D5761AB-0F57-4A5C-AC60-151E5EC46CF7

P407

Q36800215-D38E4BBC-FAC2-4F93-953E-9D7875452F47

P433

Q36800215-623E97AA-641A-4624-A7F5-A25EFA7D2099

P478

Q36800215-63815EA9-7F1C-42ED-B5B2-DC4A4E8D88FC

P577

Q36800215-53A0C07F-1704-4208-BAB4-7D237533679D

P698

Q36800215-27D3774E-6F1D-40CD-97D7-28B68BD720C9

P932

Q36800215-0766CEEE-9A6C-43E3-8B91-2A6097D73C8A

P356

JIMMUNOL.1201892

P1433

Journal of Immunology

P1476

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

@en

P2093

Chunling Ma

http://www.w3.org/2001/XMLSchema#string

Daniel F Hoft

http://www.w3.org/2001/XMLSchema#string

Eddy C Hsueh

http://www.w3.org/2001/XMLSchema#string

Eric Wevers

http://www.w3.org/2001/XMLSchema#string

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Guangyong Peng

http://www.w3.org/2001/XMLSchema#string

Jian Ye

http://www.w3.org/2001/XMLSchema#string

Mark A Varvares

http://www.w3.org/2001/XMLSchema#string

Pamela Hunborg

http://www.w3.org/2001/XMLSchema#string

Qunyuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

Tregs and rethinking cancer immunotherapy.

Gammadelta T cells: functional plasticity and heterogeneity.

Immunoregulation in the tissues by gammadelta T cells.

P304

5029-5036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1201892

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23034170

http://www.w3.org/2001/XMLSchema#string

P932

4832413

http://www.w3.org/2001/XMLSchema#string